RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) Stock Price Passes Below Fifty Day Moving Average of $0.15

RegeneRx Biopharmaceuticals, Inc. (OTCMKTS:RGRXGet Rating) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.15 and traded as low as $0.13. RegeneRx Biopharmaceuticals shares last traded at $0.15, with a volume of 10,100 shares trading hands.

RegeneRx Biopharmaceuticals Price Performance

The firm’s 50-day moving average is $0.15 and its 200 day moving average is $0.16.

About RegeneRx Biopharmaceuticals

(Get Rating)

RegeneRx Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.

Featured Articles

Receive News & Ratings for RegeneRx Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.